Navigation Links
ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
Date:4/20/2011

EXTON, Pa., April 20, 2011 /PRNewswire/ -- ViroPharma Incorporated's (Nasdaq: VPHM) first quarter financial results for 2011 are expected to be released on Thursday, April 28, 2011 before the open of the U.S. financial markets.

The company will host a conference call and live audio webcast at 9:00 a.m. Eastern Time on the same day.  During the conference call, ViroPharma management will discuss the 2011 first quarter financial results and other business.

The press release and the live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com.  An audio archive will be available at the same address until May 18, 2011.  To participate in the conference call, please dial (888) 299-4099 (domestic) and (302) 709-8337 (international).  After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.  

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is an unmet medical need, and providing rewarding careers to employees.  ViroPharma commercializes Cinryze® (C1 esterase inhibitor [human]) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE).  ViroPharma commercializes Vancocin®, approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information on ViroPharma's commercial products, please download the pack
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)
2. ViroPharma Launches HAE and Me, A New Online Community to Unite People Living With Hereditary Angioedema
3. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
4. ViroPharma Announces Securities Repurchase Program
5. ViroPharma to Participate in Two March Healthcare Conferences
6. ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
7. ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences
8. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
9. ViroPharma to Release 2010 Third Quarter Financial Results on October 27, 2010
10. ViroPharma to Present at the Jefferies 2010 Global Healthcare Conference
11. ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)...  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today that James ... has been elected to the Company,s Board of Directors, ... Anderson , Executive Chairman of CryoLife, stated, "Since joining the ... excellent leader who is well positioned to maximize CryoLife,s ...
(Date:10/22/2014)... ST. LOUIS , Oct. 21, 2014 /PRNewswire-USNewswire/ ... are often subtle or unnoticed, but new technology, ... patient outcomes and leading to earlier detection of ... now affects 29 million Americans. If left untreated, ... or even blindness. Recently, optometric ...
(Date:10/22/2014)... Mass. , Oct. 22, 2014 InVivo ... Cambridge, MA is revolutionizing spinal cord injury ... has been shown to outperform in tissue regrowth in ... the scaffold.  Made from an FDA approved polymer, the ... making it harmless to the human body. NVIV has ...
Breaking Medicine Technology:Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3
... eResearchTechnology, Inc. (ERT), (Nasdaq: ERES ), ... pharmaceutical, biotechnology, and medical device industries, today announced it ... with the Securities and Exchange Commission (the "SEC").   ... to conduct an offering of securities registered pursuant to ...
... INCLINE VILLAGE, Nev., Nov. 10, 2010 ... financial results for the third quarter and nine months ended September ... Quarter Ended September 30, 2010Revenues for the third quarter of 2010 ... million for the same period in 2009. Revenue growth for the ...
Cached Medicine Technology:ERT Files Shelf Registration Statement 2PDL BioPharma Announces Third Quarter 2010 Financial Results 2PDL BioPharma Announces Third Quarter 2010 Financial Results 3PDL BioPharma Announces Third Quarter 2010 Financial Results 4PDL BioPharma Announces Third Quarter 2010 Financial Results 5PDL BioPharma Announces Third Quarter 2010 Financial Results 6PDL BioPharma Announces Third Quarter 2010 Financial Results 7PDL BioPharma Announces Third Quarter 2010 Financial Results 8
(Date:10/22/2014)... 22, 2014 Hay House is pleased to ... and Upgrade Your Life (Paperback; $10.82) written by the highly ... Recovery. This book is meant to help readers of ... of recovery. , Recovery 2.0 is not the average ... 2.0 is a guide for what comes next. ...
(Date:10/22/2014)... Cheap Hosting USA is among the most distinguished review ... that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is the best cheap ... , “iPower is one of the most reliable hosting ... of useful products for new and old clients. What’s ... and a number of features which will appeal to ...
(Date:10/22/2014)... there are only 24 hours in a day, that doesn’t seem ... time within their busy schedules for exercise and fitness. Fortunately, one ... get in shape. Here are five ways you can reach your ... Up Your Commute , Consider riding a bike or taking the ... daily routine. If you must use your car to get to ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Akeso ... solutions for the treatment of bacterial infections, microbial biofilms, ... has joined its board of directors. , ... Engineering Systems at The Massachusetts Institute of Technology, or ... faculty since 1968. Dr. Sinskey also holds positions as ...
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
Breaking Medicine News(10 mins):Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... A study by Henry Ford Hospital shows a direct association between ... shows that in most cases the rupture heals on its own ... "In the past, many otolaryngologists have wondered if surgery is really ... show that 97 percent of cases healed on their own within ...
... (HealthDay News) -- Memory in monkeys and humans is more ... with rhesus monkeys showed that, like people, they have both ... something when you see it. Recall is the ability to ... April 28 in the journal Current Biology . ...
... Behen HealthDay Reporter , THURSDAY, April 28 ... expand research and improve understanding of cancer among minority ... the President,s Cancer Panel. While minorities currently account ... expected to become the collective majority by the year ...
... Researchers have developed an effective technique that uses gene ... in cell culture, which could eventually serve as a treatment ... study published in Blood , the ... prevents neutrophils, a type of white blood cell of the ...
... in Germany compared with the rest of Europe. Extensive folic ... 85-100% of cases, Wolfgang Herrmann and Rima Obeid argue in ... Int 2011; 108[15]; 249-54). A woman,s folic acid intake ... not develop the neural tube defect commonly known as spina ...
... The largest study of its type has found that neither ... metformin, successfully reduced liver enzymes in nonalcoholic fatty liver disease ... the April 27, 2011 issue of Journal of the ... patients with a severe type of fatty liver disease, a ...
Cached Medicine News:Health News:Study: Cotton swabs prove problematic for ear health 2Health News:'Urgent Need' for Research on Cancer Among Minorities: U.S. Report 2Health News:'Urgent Need' for Research on Cancer Among Minorities: U.S. Report 3Health News:New gene therapy technique on iPS cells holds promise in treating immune system disease 2Health News:New gene therapy technique on iPS cells holds promise in treating immune system disease 3Health News:JAMA study reports on fatty liver disease in children and teens 2
... Palladium-103 is the isotope used in ... size of an uncooked grain of ... energy radiation. Within just three months ... its energy and has lost almost ...
... for strength and durability. Four 64 mirrors ... minimal lens rotation. Choice of three handles ... Small diameter contact surface allows static or ... polymer coating protects mirrors and is compatible ...
... The best lens available ... trabeculoplasty. One 62 mirror. ... image and laser beam ... be used on most ...
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft....
Medicine Products: